PEBP2 β Antibodies

Santa Cruz Biotechnology provides a broad selection of PEBP2 β monoclonal antibodies for research in understanding PEBP2 β function and regulation. PEBP2 β monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PEBP2 β, also known as Core Binding Factor β (CBFβ), is a vital transcription factor that plays a significant role in hematopoiesis and bone development. It forms a heterodimer with the RUNX family of proteins, influencing gene expression and cellular differentiation. The proper functioning of PEBP2 β is crucial for maintaining normal cellular processes, and its dysregulation has been implicated in various hematological malignancies. PEBP2 β monoclonal antibodies enable researchers to investigate protein expression patterns across different cell types and tissues. Studying PEBP2 β localization and interactions provides valuable insights into cellular signaling pathways and disease mechanisms. Understanding PEBP2 β behavior in normal and pathological conditions can reveal new therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of PEBP2 β and its role in human health and disease.